-
Recent Posts
- Dementia-Friendly Communities Provision, Viewed as a Social Determinant of Health (JGCR / NHS England / WHO)
- International Perspectives on the Possible Impact of the COVID-19 Pandemic and Lockdown on Abuse of the Elderly (JGCR / American Journal of Geriatric Psychiatry / JAGS)
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
Archives
- September 2020
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: MRI
Cognitive and Neuroimaging Predictors of Progression from Mild Cognitive Impairment to Dementia (NHS Choices / Journal of Alzheimer’s Disease)
Summary The detection of pre-clinical Alzheimer’s Disease appears to be accomplished best by the use of a combination of information, taken from targeted neuroimaging and complementary neuropsychological assessments of cognitive functioning. This combination of approaches may be necessary in order to … Continue reading
Posted in Acute Hospitals, Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Patient Care Pathway, Quick Insights, Universal Interest
Tagged 1Institut Universitaire de Gériatrie de Montréal, Behind the Headlines, Canada, Canadian Institutes of Health Research, Canadian Institutes of Health Research (CIHR), Cortical Thickness, Cortical Thinning, Critical Appraisals, Detection of Incipient Dementia, Heart and Stroke Foundation of Canada, Hippocampal Volume, Institut Universitaire de Gériatrie de Montréal, Journal of Alzheimer's Disease, Magnetic Resonance Imaging (MRI), MCI: Mild Cognitive Impairment, Middle Frontal Gyri, Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), Montréal, MRI, MRI Brain Imaging, MRI Scans, Neuroimaging, Neuropsychological Measures, Progression of Mild Cognitive Impairment to Dementia, Right Anterior Cingulate, Transition from Cognitive Impairment to Dementia, Université de Montréal, White Matter Hyperintensities
Leave a comment
NeuroAD™ for Mild and Moderate Alzheimer’s Disease (NIHR)
Summary This briefing from the NIHR Horizon Scanning Centre outlines the principles and purpose of the NeuroAD™ system, from Neuronix. NeuroAD™ is a non-invasive treatment for patients with mild and moderate Alzheimer’s Disease. which combines focused transcranial magnetic stimulation of … Continue reading
Posted in For Doctors (mostly), For Researchers (mostly), Management of Condition, National, NIHR, Non-Pharmacological Treatments, Person-Centred Care, Quick Insights, UK
Tagged Birmingham, Cognitive Remediation Combined with Transcranial Magnetic Stimulation in Alzheimer’s Disease, Cognitive Training, Cognitive Training and rTMS in Alzheimer’s Disease, Magnetic Resonance Imaging (MRI), MRI, National Institute for Health Research (NIHR), NeuroAD™ for Mild and Moderate Alzheimer’s Disease, Neuronix (NeuroAD™ System), NIHR Horizon Scanning Centre (NIHR HSC), NIHR HSC Technology Alerts, Repetitive Transcranial Magnetic Stimulation, TMS: Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation (TMS), University of Birmingham, University of Birmingham: NIHR HSC, West Midlands
Leave a comment
Alzheimer’s Disease-Related Gray Matter Atrophy Prevention Using B-Vitamin Treatment (NHS Choices / PNAS)
Summary Researchers explored the prevention of brain atrophy in areas related to cognitive decline and Alzheimer’s disease (AD) by lowering elevated plasma homocysteine using B vitamins. An earlier study on people with increased dementia risk had indicated that high-dose B-vitamin … Continue reading
Posted in For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Nutrition, Pharmacological Treatments, Quick Insights, UK, Universal Interest
Tagged Alzheimer's Disease, Atrophy and Cognition, B vitamins (Folate B6 and B12), B-Vitamin Supplementation, B-Vitamin Treatments, Behind the Headlines, Brain Atrophy, Critical Appraisals, Diet and Alzheimer's Brain Changes, Dietary Choices, Folic Acid, Functional Magnetic Resonance Imaging of the Brain (FMRIB) Centre: University of Oxford, Gray Matter Atrophy, Homocysteine, John Radcliffe Hospital: Oxford, Magnetic Resonance Imaging (MRI), MCI, Medial Temporal Lobe, Mild Cognitive Impairment (MCI), MRI, MRI Brain Imaging, MRI Scans, Neuropsychological Tests, Nuffield Department of Clinical Neurosciences: University of Oxford, Plasma Homocysteine, PNAS, Proceedings of the National Academy of Sciences of the United States of America (PNAS), Regional Brain Atrophy, University of Oxford, Vitamin B Slows the Progression of Alzheimer’s Disease, Vitamin B12, Vitamin B6
Leave a comment
Exploring the Potential of Deep Brain Stimulation (TED Talk by Neurosurgeon Andres Lozano)
Summary Neurosurgeon Andres Lozano discusses recent developments in the potential uses of deep brain stimulation (DBS) for the alleviation of symptoms across many different neurological / neuropsychological conditions, including Parkinson’s Disease, dystonia, depression and other mental illnesses, and possibly even … Continue reading
Posted in Depression, International, Mental Health, Non-Pharmacological Treatments, Parkinson's Disease, Quick Insights, Universal Interest
Tagged Alzheimer's Disease, Andres Lozano (Neurosurgeon), Brain Imaging, Deep Brain Stimulation (DBS), Deep Brain Stimulation for the Treatment of Alzheimer Disease, Deep Brain Stimulation for the Treatment of Dementia, Dystonia, Fornix, Lewy Body Society, Magnetic Resonance Imaging (MRI), MCI, MCI: Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), MRI, MRI Scans, Neurodegeneration, Neurodegenerative Diseases, Neuroimaging, Neuroimaging of Dementia, Neurological Disease, Neurology, Neuropsychology, Nucleus Basalis of Meynert, Pre-Dementia (MCI), TED Conference, TED Talks, TEDTalks, TEDxCaltech, Toronto, Toronto Western Hospital, Treatment of Alzheimer's Disease, University of Toronto, YouTube
Leave a comment